More than 300 participants of the country’s “Mix and Match” study have already received their first dose of Sinovac vaccine, the Department of Science and Technology said Friday, Jan. 7.
Locally available vaccines under the National Immunization Program have been used in the trial. These include Sinovac, Sputnik V, AstraZeneca, Pfizer and Moderna. “As of January 5, 2022, the three sites in Marikina, Manila and Muntinlupa sites have already conducted their recruitment activities with a total of 332 vaccinated with first dose of Sinovac and 86 participants who have received their second dose of either a homologous or heterologous vaccines,” she said in an interview with the Manila Bulletin.
SinoVac is the choice of conservative ppl who don't trust the newer mRNA tech since SinoVac is made the traditional way. Even their boosters will probably be SinoVac. It's the ppl who 'don't care as long as they're protected types' who mix it 😆 At least the numbers are up!
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: manilabulletin - 🏆 25. / 51 Read more »